Dr. Reddy's Laboratories
165 hedge funds and large institutions have $1.09B invested in Dr. Reddy's Laboratories in 2014 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 54 reducing their positions, and 11 closing their positions.
164% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 11
158% more call options, than puts
Call options by funds: $1.47M | Put options by funds: $567K
17% more capital invested
Capital invested by funds: $931M → $1.09B (+$158M)
11% more funds holding
Funds holding: 149 → 165 (+16)
6.64% more ownership
Funds ownership: 66.41% → 73.05% (+6.6%)
2% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 54
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$36.4M |
| 2 |
Ninety One (UK)
London,
United Kingdom
|
+$21.9M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
+$20.4M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$13.9M |
| 5 |
TAM
Todd Asset Management
Louisville,
Kentucky
|
+$13.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
-$25.9M |
| 2 |
BG
BlackRock Group
London,
United Kingdom
|
-$22.6M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$6.78M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$5.33M |
| 5 |
TGA
Trilogy Global Advisors
Winter Park,
Florida
|
-$4.73M |
RDY Hedge Fund Activity: Q1 2014 in Review
165 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2014, worth a combined $1.09B — up 17% from $931M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new RDY positions and 11 closed out — a net gain of 18 holders — while 53 added to existing stakes and 54 trimmed.
The largest buyer was Fisher Asset Management, adding an estimated $36.4M. The largest seller was Schroder Investment Management Group, cutting an estimated $25.9M.
- 165 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2014, up from 149 in Q4 2013.
- Funds reported $1.09B of Dr. Reddy's Laboratories stock for Q1 2014, up 17% quarter-over-quarter.
- 29 funds opened new Dr. Reddy's Laboratories positions in Q1 2014 and 11 closed out, a net change of +18 holders.
- The largest Dr. Reddy's Laboratories buyer in Q1 2014 was Fisher Asset Management, an estimated $36.4M added.
- The largest Dr. Reddy's Laboratories seller in Q1 2014 was Schroder Investment Management Group, an estimated $25.9M sold.
Based on aggregated 13F filings for Q1 2014.